Cecilia Sgadari
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.
Journal: Frontiers in immunology
Published: December 16, 2025
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.
Journal: Cancer research communications
Published: February 15, 2024
Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies.
Journal: International journal of molecular sciences
Published: December 22, 2021
Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.
Journal: EBioMedicine
Published: January 14, 2021
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
Journal: Archives of virology
Published: January 14, 2021
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
Journal: International journal of molecular sciences
Published: November 19, 2020
HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Journal: Molecular cancer therapeutics
Published: January 22, 2020
HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy.
Journal: Expert review of vaccines
Published: January 21, 2020
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.
Journal: Vaccines
Published: July 16, 2019
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
Journal: Frontiers in immunology
Published: October 31, 2018
The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Journal: International journal of molecular sciences
Published: March 24, 2018
"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".
Journal: Expert review of vaccines
Published: December 16, 2017
Last Updated: 09/26/2026